Abstract:In the recent era, scientific interest has been piqued by Helicobacter pylori , a bacterium that resides in the human stomach and has been linked to a range of gastrointestinal disorders including gastritis, peptic ulcers, and an increased risk of gastric cancer. In this study, we conducted synthesis, characterization, DFT-based investigations, and in silico biological assessments of three novel dipeptide-sulphonamide derivatives to evaluate their potential as drug candidates targeting H. pylori receptors. The results of the vibrational energy distribution study were compared to the experimental vibrational frequencies, and they were found to be in good agreement. Investigation of intramolecular charge transfer interactions and stabilization energies was conducted through natural bond orbital (NBO) analysis. The analysis revealed a range of stabilization energies, with compound C exhibiting the highest energy of 657.15 kcal/mol, followed by compound A at 448.97 kcal/mol, and compound B at 418.97 kcal/mol. This order of stability correlates with their reactivity, as evidenced by energy values of 7.6693 eV for compound C, 8.4154 eV for compound A, and 8.9295 eV for compound B. These findings suggest that compound C is the most reactive among the studied species. The molecular docking results revealed that the ligands; N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(4-methylphenylsulphonamido) pentanamide (A ), N -(2-(Isobutylamino)-2-oxoethyl)-3-methyl-2-(phenylsulphonamido) pentanamide (B), and N- (2(Isobutylamino)2-oxoethyl)3-methyl-2(4-nitrophenylsulphonamido) pentanamide (C) exhibited excellent selectivity and reactivity with the protein 2QV3 compared to the standard lansoprazole. The findings clearly show that these novel dipeptide-sulphonamides could represent a new class of potential anti-ulcer agents and, with further research, could be used as new anti-ulcer medications.

Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori-Infected Mice

Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies

Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection

Novel Drug-like HsrA Inhibitors Exhibit Potent Narrow-Spectrum Antimicrobial Activities against Helicobacter pylori

Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: Crystal structure characterization with enzymatic inhibition assay

Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA

Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies

Identification and In Silico Characterization of Novel Helicobacter pylori Glucose-6-Phosphate Dehydrogenase Inhibitors

Small Molecule Inhibitors of the Response Regulator ArsR Exhibit Bactericidal Activity against Helicobacter pylori

A Multi-Methodological Approach from Virtual Screening and ADME to Molecular Dynamics Simulations

Exploring the inhibitory potential of in silico-designed small peptides on Helicobacter pylori Hp0231 (DsbK), a periplasmic oxidoreductase involved in disulfide bond formation

Paving the way for a non‐antibiotic and microbiota friendly therapy for Helicobacter pylori: In vitro and in vivo performance of lipid nanoparticles

Synthesis and Bioevaluation of Novel 3,4,5-Trimethoxybenzylbenzimidazole Derivatives That Inhibit Helicobacter Pylori-Induced Pathogenesis in Human Gastric Epithelial Cells

Resolution and Evaluation of 3-Chlorophenyl-3-hydroxypropionylhydroxamic Acid As Antivirulence Agent with Excellent Eradication Efficacy in Helicobacter Pylori Infected Mice.

High-throughput screening and molecular dynamics simulations of natural products targeting LuxS/AI-2 system as a novel antibacterial strategy for antibiotic resistance in Helicobacter pylori

Design and synthesis of novel anti-urease imidazothiazole derivatives with promising antibacterial activity against Helicobacter pylori

Molecular Dynamics Simulation-Driven Focused Virtual Screening and Experimental Validation of Fisetin As an Inhibitor of Helicobacter Pylori HtrA Protease

In Vitro and In Vivo Activities of Zinc Linolenate, a Selective Antibacterial Agent against Helicobacter pylori

Synthesis, characterization, DFT studies, and in silico biological evaluation of novel dipeptide-sulphonamide derivatives against Helicobacter pylori receptors

Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection

A Modular Synthetic Route Involving N -Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents